- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Daiichi Sankyo Company
Market Cap: JP¥5.4t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,903.00
7D
3.0%
1Y
-21.6%
Chugai Pharmaceutical
Market Cap: JP¥14.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥8,650.00
7D
-7.6%
1Y
25.8%
Takeda Pharmaceutical
Market Cap: JP¥9.1t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.
4502
JP¥5,768.00
7D
1.7%
1Y
26.7%